Journal
CELL
Volume 184, Issue 9, Pages 2471-+Publisher
CELL PRESS
DOI: 10.1016/j.cell.2021.03.011
Keywords
-
Categories
Funding
- US Department of Defense [DAMD W81XWH-16-1-0073, DAMD W81XWH-20-1-0375]
- NCI [CA183878, CA227904, CA221946, CA251950, U01CA252553]
- Breast Cancer Research Foundation
- McNair Foundation
- CPRIT Training Grant [RP160283]
- John S. Dunn Research Foundation
- T.T. and W.F. Chao Center for BRAIN
- CPRIT Scholar Award [RR160009]
- NIH [1S10OD016167]
- CPRIT Core Facility Support Award [CPRIT-RP180672]
Ask authors/readers for more resources
Metastasis is often considered the final step of tumor progression, but recent studies show that many metastases are initiated by the further spread of existing metastases. Through experiments, it was found that the bone microenvironment can facilitate cancer cells to further metastasize and establish secondary metastases in multiple organs. This metastasis-promoting effect is driven by epigenetic reprogramming that confers stem cell-like properties on disseminated cancer cells.
Metastasis has been considered as the terminal step of tumor progression. However, recent genomic studies suggest that many metastases are initiated by further spread of other metastases. Nevertheless, the corresponding pre-clinical models are lacking, and underlying mechanisms are elusive. Using several approaches, including parabiosis and an evolving barcode system, we demonstrated that the bone microenvironment facilitates breast and prostate cancer cells to further metastasize and establish multi-organ secondary metastases. We uncovered that this metastasis-promoting effect is driven by epigenetic reprogramming that confers stem cell-like properties on cancer cells disseminated from bone lesions. Furthermore, we discovered that enhanced EZH2 activity mediates the increased stemness and metastasis capacity. The same findings also apply to single cell-derived populations, indicating mechanisms distinct from clonal selection. Taken together, our work revealed an unappreciated role of the bone microenvironment in metastasis evolution and elucidated an epigenomic reprogramming process driving terminal-stage, multi-organ metastases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available